How are the Costs of Drug-Related Morbidity Measured?: A Systematic Literature Review

ISSN： 0114-5916

Source： Drug Safety, Vol.35, Iss.3, 2012-03, pp. : 207-219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

By Krähenbühl-Melcher Anita

Drug Safety, Vol. 30, Iss. 5, 2007-01 ,pp. : 379-407

Adis International

Access to resources Recommend Favorite

Preventability of Drug-Related Harms - Part I: A Systematic Review

By Ferner Robin E. Aronson Jeffrey K.

Drug Safety, Vol. 33, Iss. 11, 2010-11 ,pp. : 985-994

Adis International

Access to resources Recommend Favorite

A Systematic Review of Economic Evaluation Literature in Thailand: Are the Data Good Enough to be Used by Policy-Makers?

By Teerawattananon Yot

PharmacoEconomics, Vol. 25, Iss. 6, 2007-01 ,pp. : 467-479

Adis International

Access to resources Recommend Favorite

Is Medication Review by Primary-Care Pharmacists for Older People Cost Effective?: A Narrative Review of the Literature, Focusing on Costs and Benefits

By Zermansky Arnold G. Silcock Jonathan

PharmacoEconomics, Vol. 27, Iss. 1, 2009-01 ,pp. : 11-24

Adis International

Access to resources Recommend Favorite

New anticancer drug costs justified?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 392, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite